These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2168021)

  • 21. Effects of divalent cations on responses of a sympathetic ganglion to 5-hydroxytryptamine and 1,1-dimethyl-4-phenyl piperazinium.
    Nash HL; Wallis DI
    Br J Pharmacol; 1981 Jul; 73(3):759-72. PubMed ID: 6265020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of the indirect sympathomimetic effect of 5-hydroxytrypt-amine on the isolated heart of the rabbit.
    Fozard JR; Mwaluko GM
    Br J Pharmacol; 1976 May; 57(1):115-25. PubMed ID: 1276530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of purinoceptors mediating depolarization of rat isolated vagus nerve.
    Trezise DJ; Kennedy I; Humphrey PP
    Br J Pharmacol; 1993 Nov; 110(3):1055-60. PubMed ID: 8298793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Origin of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglion and vagus nerve.
    Ireland SJ
    Br J Pharmacol; 1987 Oct; 92(2):407-16. PubMed ID: 3676601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924.
    Sanger GJ
    Br J Pharmacol; 1987 May; 91(1):77-87. PubMed ID: 3594084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The depolarizing action of 5-HT on mammalian non-myelinated nerve fibres.
    Riccioppo Neto F
    Eur J Pharmacol; 1978 Jun; 49(4):351-6. PubMed ID: 668806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of 5-HT3 and 'atypical' 5-HT receptors mediating guinea-pig ileal contractions in vitro.
    Eglen RM; Swank SR; Walsh LK; Whiting RL
    Br J Pharmacol; 1990 Nov; 101(3):513-20. PubMed ID: 2076474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues.
    Butler A; Elswood CJ; Burridge J; Ireland SJ; Bunce KT; Kilpatrick GJ; Tyers MB
    Br J Pharmacol; 1990 Nov; 101(3):591-8. PubMed ID: 2076479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Hydroxytryptamine receptors of visceral primary afferent neurones on rabbit nodose ganglia.
    Higashi H; Nishi S
    J Physiol; 1982 Feb; 323():543-67. PubMed ID: 7097585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-HT antagonists and blockade of neuronal (5-HT) receptors on ganglion cells.
    Nash HL; Wallis DI; Ash G
    Gen Pharmacol; 1984; 15(4):339-44. PubMed ID: 6149168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.
    Butler A; Hill JM; Ireland SJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1988 Jun; 94(2):397-412. PubMed ID: 2969267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of metoclopramide, ondansetron and granisetron on aldosterone secretion in man.
    Sommers DK; Snyman JR; van Wyk M
    Eur J Clin Pharmacol; 1993; 44(4):337-9. PubMed ID: 8390368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs.
    Gullikson GW; Loeffler RF; Viriña MA
    J Pharmacol Exp Ther; 1991 Jul; 258(1):103-10. PubMed ID: 2072288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [3H]ICS 205-930 labels 5-HT3 recognition sites in membranes of cat and rabbit vagus nerve and superior cervical ganglion.
    Hoyer D; Waeber C; Karpf A; Neijt H; Palacios JM
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):396-402. PubMed ID: 2586633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for the presynaptic action of 5-hydroxytryptamine and the involvement of purinergic innervation in the rabbit lower urinary tract.
    Chen HI
    Br J Pharmacol; 1990 Sep; 101(1):212-6. PubMed ID: 2178017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties of visceral primary afferent neurons in the nodose ganglion of the rabbit.
    Stansfeld CE; Wallis DI
    J Neurophysiol; 1985 Aug; 54(2):245-60. PubMed ID: 4031986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Hydroxytryptamine depresses depolarizing responses to GABA in the rat isolated vagus nerve.
    Pike GK; Kerr DI
    Eur J Pharmacol; 1986 Nov; 131(2-3):297-300. PubMed ID: 3816958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonism of 5-hydroxytryptamine receptors by quipazine.
    Lansdown MJ; Nash HL; Preston PR; Wallis DI; Williams RG
    Br J Pharmacol; 1980 Mar; 68(3):525-32. PubMed ID: 7052342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological analysis of 5-hydroxytryptamine effects on electrically stimulated human isolated urinary bladder.
    Corsi M; Pietra C; Toson G; Trist D; Tuccitto G; Artibani W
    Br J Pharmacol; 1991 Nov; 104(3):719-25. PubMed ID: 1797331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.